BeStock  
Stocks › Biotechnology › BBIO

BridgeBio Pharma BBIO

US equityMarket cap rank #749Biotechnology
$66.02 +$0.22 (+0.33%)
Market open · Oct 1, 1:20 pm ET · After hours $65.80 0.00%
Open$65.72
Prev close$65.80
Day range$65.16 – $66.49
Volume1.02M
Market cap$12.91B
P/E (TTM)–
Dividend yield–

BBIO Stock News

Headlines matching BridgeBio Pharma or the BBIO ticker, most recent first.

  • Barclays Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $157Market news · 30 Sep 2026
  • TD Cowen Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $110Market news · 24 Sep 2026
  • BridgeBio (BBIO.US) cardiac therapy acoramidis outperforms Pfizer’s (PFE.US) competitor drug in real-world studyZhitong Finance · 24 Sep 2026
  • Evercore Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $130Market news · 14 Sep 2026
  • H.C. Wainwright Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $120Market news · 10 Sep 2026
  • A Quick Look at Today's Ratings for BridgeBio Pharma(BBIO.US), With a Forecast Between $110 to $157Market news · 1 Sep 2026
  • Piper Sandler Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $115Market news · 31 Aug 2026
  • Piper Sandler Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $111Market news · 3 Aug 2026
  • William Blair Maintains BridgeBio Pharma(BBIO.US) With Buy RatingMarket news · 3 Aug 2026
  • RBC Capital Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $100Market news · 14 Aug 2026
  • A Quick Look at Today's Ratings for BridgeBio Pharma(BBIO.US), With a Forecast Between $94 to $157Market news · 13 Aug 2026
  • A Quick Look at Today's Ratings for BridgeBio Pharma(BBIO.US), With a Forecast Between $94 to $115Market news · 12 Aug 2026
  • Analysts Are Bullish on These Healthcare Stocks: Sagimet Biosciences, Inc. Class A (SGMT), BridgeBio Pharma (BBIO)TipRanks · 12 Aug 2026
  • A Quick Look at Today's Ratings for BridgeBio Pharma(BBIO.US), With a Forecast Between $97 to $115Market news · 11 Aug 2026
  • Jefferies Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $100Market news · 6 Jul 2026

Discussion

No comments yet — be the first to weigh in on BBIO.

Leave a comment

Scroll to Top